The small trial is the first to test MDMA therapy as a treatment for addiction and the results suggest it is safe, well-tolerated and more effective than any current treatment.

In a trial involving 20 subjects, 90 percent of those in the fecal transplant group reported reduced drinking behaviors two weeks later.

Research suggests blocking kappa opioid receptor activity in the extended amygdala may help limit binge drinking behaviors.

An infusion of ketamine administered immediately after an alcohol reward memory had been triggered was found to significantly reduce drinking across the following months.

Despite a large volume of positive research in the 1950s and 60s, it is only now scientists are rekindling the idea that LSD and psilocybin could be helpful in treating alcohol use disorders.

Perhaps the most interesting body of research has investigated how the gas can potentially interfere with the recall of traumatic memories.

A robust study has uncovered a molecular mechanism in the brain that is believed central to the development of alcohol addiction.

A single dose of human mesenchymal stem cells administered to rats bred to be high alcohol drinkers significantly reduced their voluntary alcohol intake.

Electrical pulses delivered to the brains of drug users have dampened the neural response to common triggers in early trials.